Calysta

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Calysta is a privately held biotechnology company based in California that develops and commercializes microbial protein ingredients through gas-fermentation technology for use in animal feed and other food applications. Calysta uses methanotrophic bacteria to ferment methane into single-cell protein ingredients designed for aquaculture and livestock feed applications. It also uses other food ingredients. Beginning in 2016, Calysta had operated a demonstration plant in Teesside, England, that used methanotroph bacteria to convert methane into FeedKind® single cell protein under a UK government grant. The product received approval for inclusion in fish and livestock feed in the European Union. The facility was later decommissioned as the company shifted away from pilot-scale operations. Calysta was founded in 20121, based on technology developed by scientists associated with DNA2.0 (now ATUM), a US synthetic biology company. Calysta secured venture funding to commercialize its methane-to-protein technology.

Calysta is a privately held biotechnology company based in California that develops and commercializes microbial protein ingredients through gas-fermentation technology for use in animal feed and other food applications. Calysta uses methanotrophic bacteria to ferment methane into single-cell protein ingredients designed for aquaculture and livestock feed applications. It also uses other food ingredients. Beginning in 2016, Calysta had operated a demonstration plant in Teesside, England, that used methanotroph bacteria to convert methane into FeedKind® single cell protein under a UK government grant. The product received approval for inclusion in fish and livestock feed in the European Union. The facility was later decommissioned as the company shifted away from pilot-scale operations. Calysta was founded in 2012, based on technology developed by scientists associated with DNA2.0 (now ATUM), a US synthetic biology company. Calysta secured venture funding to commercialize its methane-to-protein technology.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1359352942 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia date of foundation (×1) · confidence 0.95 https://en.wikipedia.org/w/index.php?oldid=1359352942